Large-scale testing (Phase 3)Study completedNCT03398148
What this trial is testing
A Multicenter, Randomized, Double-Blind, Placebo Controlled Induction Study to Evaluate the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Ulcerative Colitis
Who this might be right for
Ulcerative Colitis (UC)
AbbVie 1,558